L&C Bio Co., Ltd (290650.KQ)

KRW 22450.0

(-1.54%)

Total Liabilities Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual total liabilities in 2023 was 105.37 Billion KRW , up 14.66% from previous year.
L&C Bio Co., Ltd's latest quarterly total liabilities in 2024 Q2 was 98.77 Billion KRW , down -7.8% from previous quarter.
L&C Bio Co., Ltd reported annual total liabilities of 91.9 Billion KRW in 2022, up 550.16% from previous year.
L&C Bio Co., Ltd reported annual total liabilities of 14.13 Billion KRW in 2021, down -26.84% from previous year.
L&C Bio Co., Ltd reported quarterly total liabilities of 107.12 Billion KRW for 2024 Q1, up 1.66% from previous quarter.
L&C Bio Co., Ltd reported quarterly total liabilities of 100.46 Billion KRW for 2023 Q2, up 2.87% from previous quarter.

Annual Total Liabilities Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Total Liabilities of L&C Bio Co., Ltd (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	105.37 Billion KRW	14.66%
2022	91.9 Billion KRW	550.16%
2021	14.13 Billion KRW	-26.84%
2020	19.32 Billion KRW	224.46%
2019	5.95 Billion KRW	30.04%
2018	4.57 Billion KRW	24.52%
2017	3.67 Billion KRW	-34.81%
2016	5.64 Billion KRW	8.52%
2015	5.19 Billion KRW	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	98.77 Billion KRW	-7.8%
2024 Q1	107.12 Billion KRW	1.66%
2023 Q2	100.46 Billion KRW	2.87%
2023 Q4	105.37 Billion KRW	-2.57%
2023 FY	105.37 Billion KRW	14.66%
2023 Q1	97.66 Billion KRW	6.27%
2023 Q3	108.14 Billion KRW	7.65%
2022 FY	91.9 Billion KRW	550.16%
2022 Q4	91.9 Billion KRW	0.88%
2022 Q3	91.1 Billion KRW	10.06%
2022 Q2	82.77 Billion KRW	322.44%
2022 Q1	19.59 Billion KRW	38.63%
2021 Q1	21.4 Billion KRW	10.77%
2021 Q4	14.13 Billion KRW	8.82%
2021 Q3	12.98 Billion KRW	56.86%
2021 Q2	8.28 Billion KRW	-61.31%
2021 FY	14.13 Billion KRW	-26.84%
2020 FY	19.32 Billion KRW	224.46%
2020 Q3	19.38 Billion KRW	3.07%
2020 Q4	19.32 Billion KRW	-0.33%
2020 Q2	18.8 Billion KRW	-16.41%
2020 Q1	22.5 Billion KRW	277.82%
2019 Q3	6.06 Billion KRW	2.05%
2019 Q4	5.95 Billion KRW	-1.81%
2019 FY	5.95 Billion KRW	30.04%
2019 Q2	5.94 Billion KRW	-8.54%
2019 Q1	6.49 Billion KRW	41.91%
2018 Q2	4.23 Billion KRW	0.0%
2018 FY	4.57 Billion KRW	24.52%
2018 Q4	4.57 Billion KRW	0.0%
2017 Q4	3.67 Billion KRW	0.0%
2017 FY	3.67 Billion KRW	-34.81%
2016 FY	5.64 Billion KRW	8.52%
2015 FY	5.19 Billion KRW	0.0%

Peer Total Liabilities Comparison of L&C Bio Co., Ltd

Name	Total Liabilities	Total Liabilities Difference
Osang Healthcare Co.,Ltd	27.25 Billion KRW	-286.61%
InBody Co.,Ltd	24.62 Billion KRW	-327.982%
Curexo Inc.	6.94 Billion KRW	-1418.136%
Seegene, Inc.	221.05 Billion KRW	52.331%
i-SENS, Inc.	195.32 Billion KRW	46.051%
Ray Co., Ltd.	128.35 Billion KRW	17.905%
Gencurix Inc.	21.49 Billion KRW	-390.146%
Sugentech Inc.	20.73 Billion KRW	-408.266%